R&D Innovation



Azurebio develops an intense research activity focusing in the application of different technologies to the development of new devices that will help to solve problems in human health. These are our main areas of research:

  • Biomaterials: as a result of research in biomaterials with new properties Azurebio has developed Sil-Oss
  • Injectable Needles: development of an alternative drug delivery format for the subcutaneous administration of vaccines and high activity drugs


We have leadered and collaborated in several research projects having received funding from public entities:


logo MINECO                        logo UE